Seiichi Kato
Papers
1
Total Citations
6
H-Index
1
About
Dr. Seiichi Kato is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for renal cell carcinoma (RCC), particularly through minimally invasive techniques. His major contributions center on the critical relationship between warm ischemic time (WIT) during partial nephrectomy and long-term renal function preservation. In his highly cited 2022 study, Dr. Kato introduced the "Trifecta" framework—a composite endpoint measuring simultaneous achievement of negative surgical margins, minimal renal function decline, and absence of complications—to evaluate the success of robotic (RAPN) and laparoscopic partial nephrectomy (LPN). This work, which has garnered 6 citations, provides surgeons with a rigorous benchmark for balancing oncologic control with nephron-sparing goals. By demonstrating that shorter WIT correlates with superior Trifecta outcomes, Dr. Kato’s research directly informs operative strategies to reduce ischemic injury. His findings have practical implications for patient counseling and surgical planning, helping to standardize quality metrics in partial nephrectomy. Through this impactful study, Dr. Kato has advanced the evidence base for robotic-assisted techniques, solidifying his reputation as a meticulous investigator dedicated to improving functional recovery after kidney cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1